Veracyte, Inc. (NASDAQ: VCYT)
$43.7500
-0.0300 ( +2.97% ) 633.1K
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.
Market Data
Open
$43.7500
Previous close
$43.7800
Volume
633.1K
Market cap
$3.39B
Day range
$41.8020 - $43.9490
52 week range
$18.6100 - $46.0000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 09, 2024 |
4 | Insider transactions | 1 | Aug 09, 2024 |
10-q | Quarterly Reports | 66 | Aug 07, 2024 |
8-k | 8K-related | 15 | Aug 06, 2024 |
4 | Insider transactions | 1 | Jul 18, 2024 |
4 | Insider transactions | 1 | Jul 18, 2024 |
4 | Insider transactions | 1 | Jul 18, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |